Literature DB >> 11357876

Chemokines in renal diseases.

T Wada1, H Yokoyama, K Matsushima, K Kobayashi.   

Abstract

The interaction of activated leukocytes and renal resident cells is thought to play a crucial role in the pathogenesis of renal diseases. Recent investigations of the pathophysiological roles of chemokines and their cognate receptors have shed light on the detailed molecular mechanisms of leukocyte trafficking and activation in the diseased kidneys. Chemokine/chemokine receptor systems may be essentially involved in the pathogenesis of phase-specific renal disorders and the measurement of urinary levels of chemokines may be clinically useful for monitoring the different disease phases and activities. In addition, chemokine receptors expressed in renal resident cells may be involved in proliferation, fibrogenesis, as well as chemotaxis. The selective intervention of chemokine/chemokine receptor systems (anti-chemokine therapy) may have the potential as the particular therapeutic strategies for renal diseases in future.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11357876     DOI: 10.1016/s1567-5769(01)00004-2

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  6 in total

1.  Macrophage Migration Inhibitory Factor Limits Renal Inflammation and Fibrosis by Counteracting Tubular Cell Cycle Arrest.

Authors:  Sonja Djudjaj; Ina V Martin; Eva M Buhl; Nina J Nothofer; Lin Leng; Marta Piecychna; Jürgen Floege; Jürgen Bernhagen; Richard Bucala; Peter Boor
Journal:  J Am Soc Nephrol       Date:  2017-08-11       Impact factor: 10.121

Review 2.  Chemokine/chemokine receptor-mediated inflammation regulates pathologic changes from acute kidney injury to chronic kidney disease.

Authors:  Kengo Furuichi; Shuichi Kaneko; Takashi Wada
Journal:  Clin Exp Nephrol       Date:  2008-12-16       Impact factor: 2.801

3.  Blockade of CCR2 ameliorates progressive fibrosis in kidney.

Authors:  Kiyoki Kitagawa; Takashi Wada; Kengo Furuichi; Hiroyuki Hashimoto; Yoshiro Ishiwata; Masahide Asano; Motohiro Takeya; William A Kuziel; Kouji Matsushima; Naofumi Mukaida; Hitoshi Yokoyama
Journal:  Am J Pathol       Date:  2004-07       Impact factor: 4.307

4.  Markers of endothelial dysfunction and inflammation predict progression of diabetic nephropathy in African Americans with type 1 diabetes.

Authors:  Monique S Roy; Malvin N Janal; Juan Crosby; Robert Donnelly
Journal:  Kidney Int       Date:  2014-06-11       Impact factor: 10.612

5.  Cytokine and Chemokine Expression in Kidneys during Chronic Leptospirosis in Reservoir and Susceptible Animal Models.

Authors:  Mariko Matsui; Louise Roche; Sophie Geroult; Marie-Estelle Soupé-Gilbert; Didier Monchy; Michel Huerre; Cyrille Goarant
Journal:  PLoS One       Date:  2016-05-24       Impact factor: 3.240

Review 6.  Role of Chemokine (C-X-C Motif) Ligand 10 (CXCL10) in Renal Diseases.

Authors:  Jie Gao; Lingling Wu; Siyang Wang; Xiangmei Chen
Journal:  Mediators Inflamm       Date:  2020-02-05       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.